Caris Life Sciences, Inc.
CAI
Rankning i aktier
#2194
Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing... Caris Life Sciences, Inc. operates as a leading "TechBio" firm, harnessing artificial intelligence to deliver comprehensive molecular profiling services to clients both in the United States and internationally. The company is dedicated to transforming medical care by innovating and bringing to market advanced solutions that leverage molecular data and sophisticated machine learning algorithms. Its extensive suite of molecular diagnostic offerings includes MI Profile, a specialized solution analyzing tissue samples, and Caris Assure, a blood-based test designed for cancer treatment applications. Furthermore, Caris provides research and development support to biopharmaceutical customers, encompassing laboratory delivery, strategic data insights, and dedicated research initiatives. Established in 2008, the company maintains its corporate headquarters in Irving, Texas.
Aktiekurs
$32.28
Senast synkroniserad: 2026-10-21
Marknadsvärde
$9.12B
Förändring (1 dag)
3.76%
Förändring (1 år)
7.46%
Land
US
Handel Caris Life Sciences, Inc. (CAI)
Kategori
Healthcare
Historik för aktiesplit för Caris Life Sciences, Inc. (CAI)
Aktien Caris Life Sciences, Inc. (symbol: CAI) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 22, 2026.
En CAI-aktie köpt före Oct 22, 2026 motsvarar nu 0 CAI-aktier.
Den senaste spliten skedde den Oct 22, 2026.
En CAI-aktie köpt före Oct 22, 2026 motsvarar nu 0 CAI-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
